Core Viewpoint - YXTT Pharmaceutical Group Co., Ltd. has approved the use of idle funds for cash management, allowing up to RMB 2.5 billion for low-risk investments to enhance fund efficiency and shareholder returns [1][5]. Group 1: Cash Management Overview - The company has signed agreements with Huaxia Bank and GF Bank for cash management, focusing on low-risk financial products [2][9]. - The cash management includes investments in fixed-income products, structured deposits, and other similar financial instruments [1][7]. Group 2: Investment Risks and Control Measures - The cash management is considered low-risk, but it is subject to market fluctuations and economic conditions, which may affect short-term returns [2][9]. - The company has established several risk control measures, including contract signing, financial analysis, internal audits, and independent oversight to mitigate potential risks [3][10]. Group 3: Impact on the Company - The cash management strategy aims to improve the efficiency of idle funds, generate investment returns, and enhance overall company performance, benefiting shareholders [5][11]. - The company emphasizes prudent investment practices to ensure that cash management does not interfere with ongoing projects or daily operations [5][11].
一心堂药业集团股份有限公司 关于使用部分暂时闲置自有资金进行现金管理的进展公告